|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Rubius Therapeutics (NASDAQ: RUBY) through any online brokerage.
The latest price target for Rubius Therapeutics (NASDAQ: RUBY) was reported by SVB Leerink on 2021-02-23. The analyst firm set a price target for 4.00 expecting RUBY to fall to within 12 months (a possible -68.15% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Rubius Therapeutics (NASDAQ: RUBY) is $12.56 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Rubius Therapeutics.
There is no upcoming split for Rubius Therapeutics.